Repros Therapeutics Inc. (Nasdaq: RPRX) announced that Nasdaq has granted the Company until May 5, 2010 to meet the continued ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE